CURRENT CLINICAL PRACTICE OF INDUCTION AND MAINTENANCE IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA

SUMMARY Current systemic treatment of metastatic renal cell carcinoma revolves around the use of interleukin‐2 and interferon‐α, often in combination with 5‐...